Clinical Trial Update: Stress Cardiac Magnetic Resonance of Asymptomatic Type 2 Diabetics with Cardiovascular High Risk to Measure Empagliflozin Impact on Myocardial Blood Flow (CATCH-EM) [NA]

View source ↗

Summary

A clinical trial registry entry for the CATCH-EM study evaluating empagliflozin's impact on myocardial blood flow in asymptomatic adults with type 2 diabetes an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Microvascular Coronary Artery Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: The University of Hong Kong | Conditions: Type 2 Diabetes, Microvascular Coronary Artery Disease | NA | Status: ACTIVE_NOT_RECRUITING